<html>
<head>
<title>Section 126-A:68 Commission to Study Oversight, Regulation, and Reporting of Patient Safety and Infectious Disease Prevention and Control Issues Established.</title>
<!-- Hide metadata
<titlename>TITLE X PUBLIC HEALTH</titlename>
<chapter>CHAPTER 126-A DEPARTMENT OF HEALTH AND HUMAN SERVICES</chapter>
<sectiontitle>Section 126-A:68 Commission to Study Oversight, Regulation, and Reporting of Patient Safety and Infectious Disease Prevention and Control Issues Established.</sectiontitle>
-->
<meta name="titlename" content="TITLE X PUBLIC HEALTH">
<meta name="chapter" content="CHAPTER 126-A DEPARTMENT OF HEALTH AND HUMAN SERVICES">
<meta name="sectiontitle" content="Section 126-A:68 Commission to Study Oversight, Regulation, and Reporting of Patient Safety and Infectious Disease Prevention and Control Issues Established.">
<meta name="sourcenote" content="Source.  2015, 147:2, eff. June 12, 2015.">
<meta name="codesect" content="<br>&nbsp&nbsp&nbspI. There is established a commission to study oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues in health care settings.<br>&nbsp&nbsp&nbspII. The members of the commission shall be as follows:<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(a) One member of the senate, appointed by the president of the senate.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(b) Three members of the house of representatives, appointed by the speaker of the house of representatives.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(c) The director of the division of public health services, department of health and human services, or designee.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(d) The bureau chief for the bureau of health facilities administration, department of health and human services, or designee.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(e) A representative of the New Hampshire board of dental examiners, appointed by the board.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(f) A representative of the New Hampshire board of medicine, appointed by the board.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(g) A representative from the New Hampshire board of nursing, appointed by the board.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(h) A representative from the New Hampshire board of pharmacy, appointed by the board.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(i) A representative from the New Hampshire board of podiatry, appointed by the board.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(j) A representative from the New Hampshire Foundation for Healthy Communities, appointed by the foundation.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(k) A representative from the New Hampshire Hospital Association, appointed by the association.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(l) A physician from the New Hampshire Medical Society, appointed by the society.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(m) A dentist from the New Hampshire Dental Society, appointed by the society.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(n) A representative from the New Hampshire Ambulatory Surgery Center Association, appointed by the association.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(o) A representative from the New Hampshire Infection Control and Epidemiology Professionals, appointed by that organization.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(p) A representative of a nursing home facility, appointed by the New Hampshire Health Care Association.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(q) Two public members, at least one of whom shall be an independent office-based health care practitioner, appointed by the governor.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(r) An APRN, appointed by the New Hampshire Nurse Practitioner Association.<br>&nbsp&nbsp&nbspIII. The commission shall be an administratively attached agency, under RSA 21-G:10, to the department of health and human services.<br>&nbsp&nbsp&nbspIV. Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.<br>&nbsp&nbsp&nbspV. The commission's study shall include, but not be limited to:<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(a) Conducting an assessment of the existing framework for the oversight, regulation, and reporting of patient safety concerns related to infectious disease prevention and control issues among health care delivery settings, focused on, but not limited to, private, unlicensed, and/or unaffiliated health care settings, to help coordinate response to any arising infectious disease prevention and control concerns.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(b) Evaluating credentialing and regulatory oversight to determine unforeseen or hidden gaps which may pose barriers to timely and effective public health response to infectious disease prevention and control concerns in health care settings.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(c) Reviewing coordination of interagency communication relating to any infectious disease prevention and control concern across health care delivery settings including, but not limited to, private, unlicensed, and/or unaffiliated health care settings.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(d) Discussing potential deficits and areas for improvement in the current framework of regulatory oversight with a goal to identify recommended solutions, both legislative and non-legislative.<br>&nbsp&nbsp&nbspVI. The members of the commission shall elect a chairperson from among the members.  The first meeting of the commission shall be called by the senate member.  The first meeting of the commission shall be held within 60 days of the effective date of this section.  Eleven members of the commission shall constitute a quorum.<br>&nbsp&nbsp&nbspVII. The commission shall report its findings and any recommendations for proposed legislation to the president of the senate, the speaker of the house of representatives, the chairperson of the health and human services oversight committee established under RSA 126-A:13, the senate clerk, the house clerk, the governor, and the state library on or before November 1, 2015.">
</head>
<body>
<center><h1>TITLE X<br>PUBLIC HEALTH</h1></center>
<center><h2>CHAPTER 126-A<br>DEPARTMENT OF HEALTH AND HUMAN SERVICES</h2></center>
<center><h2>Commission to Study Oversight, Regulation, and Reporting of Patient Safety and Infectious Disease Prevention and Control Issues</h2></center>
<center><h3>Section 126-A:68</h3></center>
<br><center>[RSA 126-A:68 repealed by 2015, 147:3, effective November 1, 2015.]</center>
&nbsp;&nbsp;&nbsp;<b> 126-A:68 Commission to Study Oversight, Regulation, and Reporting of Patient Safety and Infectious Disease Prevention and Control Issues Established. &#150;</b>
<codesect>
<br>
&nbsp&nbsp&nbsp
I. There is established a commission to study oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues in health care settings.
<br>
&nbsp&nbsp&nbsp
II. The members of the commission shall be as follows:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) One member of the senate, appointed by the president of the senate.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) Three members of the house of representatives, appointed by the speaker of the house of representatives.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) The director of the division of public health services, department of health and human services, or designee.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(d) The bureau chief for the bureau of health facilities administration, department of health and human services, or designee.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(e) A representative of the New Hampshire board of dental examiners, appointed by the board.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(f) A representative of the New Hampshire board of medicine, appointed by the board.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(g) A representative from the New Hampshire board of nursing, appointed by the board.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(h) A representative from the New Hampshire board of pharmacy, appointed by the board.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(i) A representative from the New Hampshire board of podiatry, appointed by the board.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(j) A representative from the New Hampshire Foundation for Healthy Communities, appointed by the foundation.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(k) A representative from the New Hampshire Hospital Association, appointed by the association.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(l) A physician from the New Hampshire Medical Society, appointed by the society.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(m) A dentist from the New Hampshire Dental Society, appointed by the society.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(n) A representative from the New Hampshire Ambulatory Surgery Center Association, appointed by the association.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(o) A representative from the New Hampshire Infection Control and Epidemiology Professionals, appointed by that organization.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(p) A representative of a nursing home facility, appointed by the New Hampshire Health Care Association.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(q) Two public members, at least one of whom shall be an independent office-based health care practitioner, appointed by the governor.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(r) An APRN, appointed by the New Hampshire Nurse Practitioner Association.
<br>
&nbsp&nbsp&nbsp
III. The commission shall be an administratively attached agency, under RSA 21-G:10, to the department of health and human services.
<br>
&nbsp&nbsp&nbsp
IV. Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.
<br>
&nbsp&nbsp&nbsp
V. The commission's study shall include, but not be limited to:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) Conducting an assessment of the existing framework for the oversight, regulation, and reporting of patient safety concerns related to infectious disease prevention and control issues among health care delivery settings, focused on, but not limited to, private, unlicensed, and/or unaffiliated health care settings, to help coordinate response to any arising infectious disease prevention and control concerns.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) Evaluating credentialing and regulatory oversight to determine unforeseen or hidden gaps which may pose barriers to timely and effective public health response to infectious disease prevention and control concerns in health care settings.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) Reviewing coordination of interagency communication relating to any infectious disease prevention and control concern across health care delivery settings including, but not limited to, private, unlicensed, and/or unaffiliated health care settings.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(d) Discussing potential deficits and areas for improvement in the current framework of regulatory oversight with a goal to identify recommended solutions, both legislative and non-legislative.
<br>
&nbsp&nbsp&nbsp
VI. The members of the commission shall elect a chairperson from among the members.  The first meeting of the commission shall be called by the senate member.  The first meeting of the commission shall be held within 60 days of the effective date of this section.  Eleven members of the commission shall constitute a quorum.
<br>
&nbsp&nbsp&nbsp
VII. The commission shall report its findings and any recommendations for proposed legislation to the president of the senate, the speaker of the house of representatives, the chairperson of the health and human services oversight committee established under RSA 126-A:13, the senate clerk, the house clerk, the governor, and the state library on or before November 1, 2015.
</codesect>
<sourcenote>
<p><b>Source.</b>  2015, 147:2, eff. June 12, 2015.</p>
</sourcenote>
</body>
</html>
